又一家 AI 明星公司诞生：曝“医生版 ChatGPT”OpenEvidence 估值冲上 150 亿美元

AI Digest

OpenEvidence以150亿美元估值成为AI医疗明星企业，获2.5亿美元融资，与多家科技公司合作，服务超三分之二美国医生。

OpenEvidence, dubbed 'doctor's ChatGPT', reaches $15B valuation with $250M funding, partners with major tech firms and serves over two-thirds of US physicians.

Key points

• 获2.5亿美元融资估值达150亿美元，医疗AI领域罕见 Secures $250M funding boosting valuation to $15B, rare in medical AI
• 与英伟达、Anthropic等科技巨头建立深度合作 Establishes partnerships with NVIDIA, Anthropic, and tech giants
• 服务美国超三分之二医生，成为医疗AI标杆 Serves over two-thirds of US physicians as medical AI benchmark
• 或被收购或保持独立，反映行业整合趋势 Potential acquisition or independence reflects industry consolidation
• AI医疗工具加速发展，挑战传统诊疗模式 AI medical tools accelerate development challenging traditional practices

Takeaway: AI医疗赛道出现现象级企业，预示医疗数字化转型加速。 / Medical AI emerges as a game-changer, signaling accelerated digital transformation in healthcare.

Why it matters 揭示AI医疗领域快速崛起与商业潜力，展现技术对传统医疗模式的颠覆性影响。